SCHEMBL7938314

SCHEMBL7938314

C=CC[C](Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.44
CES2 O00748 1/20 0.44
AKR1B1 P15121 1/20 0.44
TSHR P16473 2/20 0.39
GAA P10253 2/20 0.39
ABCC4 O15439 1/20 0.39
LMNA P02545 1/20 0.39
PTGS1 P23219 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
SRD5A2 P31213 1/20 0.37
MAOB P27338 1/20 0.37
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8673012 0.95 CES1 (0.44) CES1CES2AKR1B1TSHRGAA
SCHEMBL4376010 0.80 CES1 (0.43) CES1CES2AKR1B1TSHRGAA
SCHEMBL8667927 0.78 CES1 (0.41) CES1CES2AKR1B1TSHRGAA
SCHEMBL7211952 0.78 CES1 (0.41) CES1CES2AKR1B1TSHRGAA
SCHEMBL2456680 0.78 CES1 (0.52) CES1CES2AKR1B1TSHRGAA
SCHEMBL4981463 0.77 CES1 (0.60) CES1CES2AKR1B1TSHRMEN1
SCHEMBL6414155 0.77 CES1 (0.40) CES1CES2AKR1B1TSHRGAA
SCHEMBL9709391 0.74 CES1 (0.47) CES1CES2AKR1B1TSHRGAA
SCHEMBL9860999 0.74 CES1 (0.47) CES1CES2AKR1B1TSHRGAA
SCHEMBL9709396 0.74 CES1 (0.47) CES1CES2AKR1B1TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242052-B1 BENZIMIDAZOLE COMPOUND BASF COATINGS AG (DE) 2001-06-05 US claimed
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed